Pure Biologics

Pure Biologics Share Buybacks

The Share Buybacks of Pure Biologics (PUR.WA) as of Oct 19, 2026 is 9.54 M PLN. In the previous year, Share Buybacks was 2.70 M PLN — a change of 253.28% (higher).

Share Buybacks

9.54 MPLN

YoY

253.28%

Last updated:

Share Buybacks of Pure Biologics is 2019 9.54 M PLN. Share Buybacks of Pure Biologics was 2018 2.70 M PLN. It decreases by 253.28% higher compared to the previous year.

The Pure Biologics Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2017
310,800.00 PLN
Jan 1, 2018
2.70 M PLN
Jan 1, 2019
9.54 M PLN
The Pure Biologics Share Buybacks history
YEARShare BuybacksYoY
9.54 MPLN+253.28%
2.70 MPLN+768.87%
310,800.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

Share Buybacks of Pure Biologics is 9.54 M PLN in 2019.

Share Buybacks of Pure Biologics changed from 2.70 M PLN to 9.54 M PLN, representing a 253.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Share Buybacks Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Pure Biologics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Pure Biologics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Pure Biologics